Pleiotropic behavior of 5-HT2A
and 5-HT2C receptor agonists
by
Berg KA, Maayani S, Goldfarb J, Clarke WP
Department of Pharmacology,
University of Texas Health Science Center,
San Antonio 78284-7764, USA.
Br J Psychiatry 1997 Nov; 171:444-8

ABSTRACT

There is now considerable evidence that a single receptor subtype can couple to multiple effector pathways within a cell. Recently, Kenakin proposed a new concept, termed "agonist-directed trafficking of receptor stimulus", that suggests that agonists may be able to selectively activate a subset of multiple signaling pathways coupled to a single receptor subtype. 5-HT2A and 5-HT2C receptors couple to phospholipase C-(PLC) mediated inositol phosphate (IP) accumulation and PLA2-mediated arachidonic acid (AA) release. Relative efficacies of agonists (referenced to 5-HT) differed depending upon whether IP accumulation or AA release was measured. For the 5-HT2C receptor system, some agonists (e.g. TFMPP) preferentially activated the PLC-IP pathway, whereas others (e.g. LSD) favored PLA2-AA. As expected, EC50's of agonists did not differ between pathways. For the 5-HT2A receptor system, all agonists tested had greater relative efficacy for PLA2-AA than for PLC-IP. In contrast, relative efficacies were not different for 5-HT2A agonists when sequential effects in a pathway were measured (IP accumulation vs. calcium mobilization). These data strongly support the agonist-directed trafficking hypothesis.

LSD
SSRIs
5-HT2
5-HT3
5-HT4
5-H2c
5-HT1a
5-HT2a
5-HT1d
Serotonin
Agomelatine
5-HT2a antagonists
New antidepressants
Serotonin 5-HT2C receptors
Serotonergic genes and suicide
5-HT7 receptor antagonists as antidepressants
Depression, SSRIs and the serotonin 5-HT2 receptors

Refs
HOME
HedWeb
Future Opioids
BLTC Research
Paradise-Engineering
Utopian Pharmacology
The Hedonistic Imperative
When Is It Best To Take Crack Cocaine?

The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family